Class: Cathartics and Laxatives
ATC Class: A06AX02
VA Class: GA200
CAS Number: 124-38-9
Brands: Ceo-Two, Fleet Enema, Fleet Pedia-Lax, Fleet Prep Kit, LoSo Prep Kit, OsmoPrep, Phillips' Milk of Magnesia, Phillips' M-O, Tridrate Kit, Visicol
REMS:
FDA approved a REMS for sodium phospate to ensure that the benefits of a drug outweigh the risks. The REMS may apply to one or more preparations of sodium phospate and consists of the following: medication guide and communication plan. See the FDA REMS page () or the ASHP REMS Resource Center ().
Introduction
Laxatives containing magnesium cations or phosphate anions.a
Uses for Saline Laxatives
Constipation
Used to relieve occasional constipation.214 215 216 217 218 219 220 224 225 227 231 b
Use of saline laxatives for simple constipation is seldom necessary or desirable; bulk-forming laxatives are drugs of choice.b
Do not use rectal suppositories or enemas if oral laxatives are effective.b
Mild saline laxatives (e.g., oral magnesium hydroxide, milk of magnesia) have been used to treat constipation during pregnancy or the puerperium; bulk-forming laxatives or stool softeners preferred.b
Used rectally, after administration of a stool softener or mineral oil, to evacuate the impacted colon in the treatment of constipation associated with stricture of the colon or fecal impaction.b Alternatively, administer phosphate-containing saline enemas rectally after manual disimpaction to promote evacuation of fecal impactions.b
Bowel Cleansing
Used orally and/or rectally (as suppositories or enemas) to empty the bowel prior to surgery or radiologic, proctoscopic, or endoscopic procedures, when thorough evacuation is essential.212 213 219 220 221 222 223 227 232 b Oral therapy often is supplemented with rectal evacuants.221 222 223 232 b
FDA recommends using OTC oral sodium phosphates preparations for bowel cleansing only when a prescription for such use has been issued by a clinician.239 240 (See Renal Effects under Cautions.)
Poisonings
May hasten removal of some poisons† from the GI tract after inducing emesis or performing gastric lavage.b Not for use after poisonings with ingested acids or alkalies.b Magnesium laxatives should not be used to remove poisons that produce CNS depression or renal function impairment.b
Saline Laxatives Dosage and Administration
General
- Bowel Cleansing
Patients must drink sufficient quantities of clear fluids (minimum of 1.9–3.4 L per regimen, depending on the specific regimen).212 213 220 221 222 223 229 230 b Use IV hydration in a hospital setting for fragile patients with inadequate home support or who are unable to drink an appropriate fluid volume.239 b (See Fluid Intake under Cautions.)
Administration
Administer magnesium-containing saline laxatives orally as chewable tablets, suspensions, or solutions.215 216 217 218 222 223 224 225 232
Administer phosphate-containing laxatives orally as solutions or tablets and rectally as enemas.212 213 219 220 221 227 228 229 230 Do not administer commercially available phosphate-containing rectal enema solutions orally.219 227 228
Administer carbon dioxide-releasing suppositories (e.g., CEO-TWO) rectally.214
Select rectal phosphate-containing laxatives carefully to ensure appropriate volume for age to minimize risk of overdosage.219 227 228
Administer laxatives as infrequently as possible at the lowest effect dosage level.b Do not use for >7 days unless directed by prescriber.215 216 b
Administer laxatives with sufficient fluids (i.e., 240 mL) to prevent dehydration from repeated administration.215 216 217 218 224 225 233 b (See Fluid Intake under Cautions.)
Oral Administration
Administer orally as magnesium-containing chewable tablets, suspensions, or solutions or as phosphate-containing solutions or tablets.212 213 215 216 217 218 219 220 221 222 223 224 225 227 228 229 230 232 233 235
Do not administer fixed combination of magnesium hydroxide and mineral oil with meals; typically administered at bedtime.218
Shake suspensions well before use.215 216 218
May refrigerate oral sodium phosphates solutions to improve taste;220 may drink magnesium citrate chilled.222
Reconstitution (Magnesium Sulfate Crystals)
To prepare magnesium sulfate oral solution, dissolve appropriate dose of the crystals in at least 240 mL water; may add lemon juice to mask bitter taste and minimize nausea.225 b
Reconstitution (LoSo Prep Kit)
Prepare magnesium citrate oral solution by dissolving contents of 1 packet (18 g of magnesium citrate) in 240 mL of cold water.232 First, add approximately one-half of the contents of the packet to a large (capacity of ≥480 mL) glass containing 240 mL of cold water, gently stir the mixture until effervescence (fizzing) stops, then add the remaining contents of the packet to the mixture and again stir gently until effervescence stops.232
Reconstitution (Tridrate Dry Kit)
Prepare magnesium citrate oral solution by adding the contents of 1 packet (19 g of magnesium citrate) to 240 mL of room-temperature water; stir the mixture for 30 seconds until complete dissolution occurs.226 Patient should wait ≥20 minutes before ingesting the mixture, occasionally stirring it in the interim.226 May prepare the solution up to 12 hours prior to ingestion and chill to improve taste.226
Dilution (Fleet Prep Kits)
Dilute sodium phosphates oral solution (Fleet Phospho-soda) prior to administration.220 229 230 Mix 45 mL of the solution with 360 mL of cold clear liquid (ginger ale, apple juice, Sprite, or 7-Up may help improve taste).220 229 230
Rectal Administration
Administer rectally as phosphate-containing enemas or carbon dioxide-releasing suppositories.214 219 227 228
Suppositories
Carbon dioxide-releasing suppositories: Remove wrapper and moisten under a warm-water tap for 30 seconds or in a cup of water for ≥10 seconds prior to rectal insertion;214 231 234 do not use mineral oil or petroleum jelly to lubricate.214 231 234
Insert suppository high into the rectum past the largest diameter of the suppository;214 retain for as long as possible (usually 5–30 minutes) before defecating.214 231 b
Enemas
Administer sodium phosphates enema at room temperature.219
Remove protective shield (if present) from tip of enema.219 228
Before administering, lie on left side with knees bent or kneel on the bed with head and chest lowered and forward until the left side of the face is resting on the surface of the bed.219 228 b
With steady pressure, insert enema nozzle into rectum, with nozzle pointed toward the navel.219 b To ease insertion, have patient bear down as if having a bowel movement.219 Squeeze container until nearly all the liquid is expelled.219 228 b Use caution to avoid bowel perforation.219 If resistance is encountered during insertion or administration, discontinue procedure to avoid perforation or rectal abrasion.219
Retain until definite lower abdominal cramping felt.b Complete evacuation of the left colon usually occurs within 1–5 minutes.219
Disposable enemas are for single-use only.219
For children 2–4 years of age, prepare an enema containing dibasic sodium phosphate 1.75 g and monobasic sodium phosphate 4.75 g in approximately 29 mL for administration as follows.227 Unscrew the cap of a pediatric-strength enema containing dibasic sodium phosphate 3.5 g and monobasic sodium phosphate 9.5 g in 59 mL (e.g., Fleet Pedia-Lax Enema) and remove 30 mL of solution.227 Replace the cap and administer the enema as directed.227
Dosage
Most studies suggest that the minimum effective oral laxative dose of magnesium is 80 mEq.a (See Electrolytic Content under Cautions.)
Magnesium sulfate crystals: Each level teaspoonful of crystals provides approximately 5 g of magnesium sulfate and 495 mg (40.7 mEq) of magnesium.225
Sodium phosphates enemas: A 66-mL enema (Fleet Pedia-Lax Enema) delivers a dose of 3.5 g of dibasic sodium phosphate and 9.5 g of monobasic sodium phosphate in 59 mL;227 a 133-mL enema (Fleet Enema) delivers a dose of 7 g of dibasic sodium phosphate and 19 g of monobasic sodium phosphate in 118 mL; a 230-mL enema (Fleet Enema Extra) delivers a dose of 7 g of dibasic sodium phosphate and 19 g of monobasic sodium phosphate in 197 mL.219
Pediatric Patients
Constipation
Laxatives should be used as infrequently as possible, at the lowest effective dosage level, and usually for ≤7 days; laxatives should be used for longer periods only under the management of a clinician and as part of a carefully planned therapeutic regimen.214 215 216 217 218 219 220 221 223 225 232 (See Chronic Use or Overdosage under Cautions.)
Magnesium Citrate
Oral
Children 2–5 years of age: For self-medication, 2.7–6.25 g (usually 60–90 mL [3.5–5.25 g] of a 291-mg/5-mL oral solution224 ) as a single daily dose or in divided doses.234
Children 6–11 years of age: For self-medication, 5.5–12.5 g (usually 90–150 mL [5.25–8.75 g] of a 291-mg/5-mL oral solution224 ) as a single daily dose or in divided doses.234
Children ≥12 years of age: For self-medication, 8.75–25 g (usually 150–300 mL [8.75–17.5 g] of a 291-mg/5-mL oral solution224 ) as a single daily dose or in divided doses.234
Magnesium Hydroxide
Oral
Children 2–5 years of age: For self-medication, 0.4–1.2 g daily given as a single dose (preferably at bedtime), in divided doses, or as directed by a clinician.217 233 234 235
Children 6–11 years of age: For self-medication, 1.2–2.4 g daily given as a single dose (preferably at bedtime), in divided doses, or as directed by a clinician.215 216 217 218 233 234 235
Children ≥12 years of age: For self-medication, 2.4–4.8 g daily given as a single dose (preferably at bedtime), in divided doses, or as directed by a clinician.215 216 217 218 233 234
Magnesium Sulfate
Oral
Children 2–5 years of age: For self-medication, 2.5–5 g daily given as a single dose or in divided doses.234
Children 6–11 years of age: For self-medication, 5–10 g daily given as a single dose or in divided doses.225 234
Children ≥12 years of age: For self-medication, 10–30 g daily given as a single dose or in divided doses.225 234
Fixed Combination of Magnesium Hydroxide and Mineral Oil
Oral
Do not use manufacturer's provided dosage cup for Phillips' M-O for children.218
Children 6–11 years of age: For self-medication, 1.2–1.8 g of magnesium hydroxide (20–30 mL of the fixed-combination suspension) daily given as a single dose (at bedtime), in divided doses, or as directed by a clinician.218
Children ≥12 years of age: For self-medication, 2.7–3.6 g of magnesium hydroxide (45–60 mL of the fixed-combination suspension) daily given as a single dose (at bedtime), in divided doses, or as directed by a clinician.218
Sodium Phosphates Enemas
Rectal
Do not administer adult-size Fleet enemas to children <12 years of age.219 Do not administer a full 59-mL Fleet Pedia-Lax Enema to children <5 years of age.219 227
Children 2–4 years of age: For self-medication, 1.75 g of dibasic sodium phosphate and 4.75 g of monobasic sodium phosphate (½ bottle [approximately 29 mL] of Fleet Pedia-Lax Enema) given as a single daily dose.227 To obtain correct dose, remove 30 mL liquid from Fleet Pedia-Lax Enema prior to administration.227
Children 5–11 years of age: For self-medication, 3.5 g of dibasic sodium phosphate and 9.5 g of monobasic sodium phosphate (1 bottle [approximately 59 mL] of Fleet Pedia-Lax Enema) given as a single daily dose or as directed by a clinician.227
Children ≥12 years of age: For self-medication, 7 g of dibasic sodium phosphate and 19 g of monobasic sodium phosphate (1 bottle of Fleet Enema [approximately 118 mL] or Fleet Enema Extra [approximately 197 mL]) given as a single daily dose.219 228
Carbon Dioxide-releasing Suppositories
Rectal
Children ≥12 years of age: For self-medication, 1 suppository (0.9 g potassium bitartrate and 0.6 g sodium bicarbonate) given as a single daily dose.214 231 234
Bowel Cleansing
Consult manufacturers' instructions for details (e.g., time of administration) of the specific regimen to be used to clear the bowel prior to surgical, radiologic, or endoscopic procedures.222 223 226 232
Fleet Sodium Phosphates Enemas
Rectal
Do not administer adult-size Fleet enemas to children <12 years of age.219 Do not administer a full 59-mL Fleet Pedia-Lax Enema to children <5 years of age.219 227
Children 2–4 years of age: For self-medication, 1.75 g of dibasic sodium phosphate and 4.75 g of monobasic sodium phosphate (½ bottle [approximately 29 mL] of Fleet Pedia-Lax Enema) given as a single daily dose.227 To obtain correct dose, remove 30 mL liquid from Fleet Pedia-Lax Enema prior to administration.227
Children 5–11 years of age: For self-medication, 3.5 g of dibasic sodium phosphate and 9.5 g of monobasic sodium phosphate (1 bottle [approximately 59 mL] of Fleet Pedia-Lax Enema) given as a single daily dose or as directed by a clinician.227
Children ≥12 years of age: For self-medication, 7 g of dibasic sodium phosphate and 19 g of monobasic sodium phosphate (1 bottle of Fleet Enema [approximately 118 mL] or Fleet Enema Extra [approximately 197 mL]) given as a single daily dose.219 228
Liquid LoSo Prep Kit
Oral and Rectal
The regimen begins with liquid meals at prescribed times, followed by scheduled clear liquid intake at various times and scheduled administration of oral laxatives, and concludes with rectal administration of a bisacodyl suppository.223
Children ≥12 years of age: In the usual regimen, 300 mL of magnesium citrate solution (17.45 g of magnesium citrate) is administered orally at 5:30 p.m. the day before the procedure, followed by 20 mg of bisacodyl orally at 7:30 p.m. the day before the procedure, and concludes with a 10-mg bisacodyl rectal suppository inserted at least 2 hours before the procedure.223
LoSo Prep Kit
Oral and Rectal
The regimen begins with liquid meals at prescribed times, followed by scheduled clear liquid intake at various times and scheduled administration of oral laxatives, and concludes with rectal administration of a bisacodyl suppository.232
Children ≥12 years of age: In the usual regimen, 18 g of magnesium citrate (1 packet dissolved in 240 mL water) is administered orally at 5:30 p.m. the day before the procedure, followed by 20 mg of bisacodyl orally at 7:30 p.m. the day before the procedure, and concludes with a 10-mg bisacodyl rectal suppository inserted at least 2 hours before the procedure.232
Tridrate Kit
Oral and Rectal
The regimen begins with a meal (i.e., clear liquids, chicken or turkey white meat sandwich without condiments, skim milk) at a prescribed time, followed by scheduled clear liquid intake at various times and scheduled administration of oral laxatives, and concludes with rectal administration of a bisacodyl suppository.222
Children >12 years of age: In the usual regimen, 300 mL of magnesium citrate solution is administered orally at 8 p.m. the day before the procedure, followed by 15 mg of bisacodyl orally at 10 p.m. the day before the procedure, and concludes with a 10-mg bisacodyl rectal suppository at 7 a.m. the morning of the procedure.222
Tridrate Dry Kit
Oral and Rectal
The regimen begins with liquid meals at prescribed times, followed by scheduled clear liquid intake at various times and scheduled administration of oral laxatives, and concludes with rectal administration of a bisacodyl suppository.226
Children >12 years of age: In the usual regimen, 19 g of magnesium citrate (1 packet dissolved in 240 mL water) is administered orally in 2 divided doses at 6 p.m. and 6:15 p.m. the day before the procedure, followed by 15 mg of bisacodyl orally at bedtime (between 9 p.m. and midnight) the day before the procedure, and concludes with a 10-mg bisacodyl rectal suppository at 7 a.m. the morning of (at least 2 hours before) the procedure.226
Adults
Constipation
Laxatives should be used as infrequently as possible, at the lowest effective dosage level, and usually for ≤7 days; laxatives should be used for longer periods only under the management of a clinician and as part of a carefully planned therapeutic regimen.214 215 216 217 218 219 220 221 223 225 232 b (See Chronic Use or Overdosage under Cautions.)
Magnesium Citrate
Oral
For self-medication: 8.75–25 g (usually 150–300 mL of a 291-mg/5-mL oral solution224 ) as a single daily dose or in divided doses.234
Magnesium Hydroxide
Oral
For self-medication: 2.4–4.8 g daily given as a single dose (preferably at bedtime), in divided doses, or as directed by a clinician.215 216 217 218 233 234
Magnesium Sulfate
Oral
For self-medication: 10–30 g daily given as a single dose or in divided doses.225 234
Fixed Combination of Magnesium Hydroxide and Mineral Oil
Oral
For self-medication: 2.7–3.6 g of magnesium hydroxide (45–60 mL of the fixed-combination suspension) daily given as a single dose (at bedtime), in divided doses, or as directed by a clinician.218
Sodium Phosphates Enemas
Rectal
For self-medication: 7 g of dibasic sodium phosphate and 19 g of monobasic sodium phosphate (1 bottle of Fleet Enema [approximately 118 mL] or Fleet Enema Extra [approximately 197 mL]) given as a single daily dose.219 228
Carbon Dioxide-releasing Suppositories
Rectal
1 suppository (0.9 g potassium bitartrate and 0.6 g sodium bicarbonate) given as a single daily dose.214 231 234
Bowel Cleansing
Fleet Prep Kits
Oral and Rectal
Available in 2 kit combinations containing sodium phosphates oral solution, bisacodyl tablets, and either a bisacodyl suppository (Fleet Prep Kit 1) or a bisacodyl enema (Fleet Prep Kit 3).221
Each kit can be administered in regimens beginning 18 or 24 hours before the procedure; in most cases, the 24-hour regimen is followed.221
Each regimen begins with a light meal at a prescribed time, followed by scheduled clear liquid intake at various times and scheduled administration of oral laxatives, and concludes with rectal administration of either a bisacodyl suppository or bisacodyl enema 1 hour before leaving for the procedure.221
Kit 1, 24-hour regimen: The day before the procedure, 45 mL of sodium phosphates oral solution (Fleet Phospho-soda) is mixed with 360 mL of cold clear liquid and administered orally at 4 p.m. with ≥360 mL of clear liquid, followed by 20 mg (or alternative dose per clinician) of bisacodyl orally at 9 p.m. the day before the procedure, and then by a 10-mg bisacodyl rectal suppository administered 1 hour before leaving for the procedure.221 229
Kit 3, 24-hour regimen: The day before the procedure, 45 mL of sodium phosphates oral solution (Fleet Phospho-soda) is mixed with 360 mL of cold clear liquid and administered orally at 4 p.m. with ≥240 mL of clear liquid, followed by 20 mg (or alternative dose per clinician) of bisacodyl orally at 9 p.m. the day before the procedure, and then by a 10-mg (30-mL) bisacodyl enema administered 1 hour before leaving for the procedure.221 230
Drink as much additional liquid as possible; drink additional liquids after procedure to prevent dehydration.221 229 230
Sodium Phosphates Enemas
Rectal
For self-medication: 7 g of dibasic sodium phosphate and 19 g of monobasic sodium phosphate (1 bottle of Fleet Enema [approximately 118 mL] or Fleet Enema Extra [approximately 197 mL]) given as a single daily dose.219 228
Liquid LoSo Prep Kit
Oral and Rectal
The regimen begins with liquid meals at prescribed times, followed by scheduled clear liquid intake at various times and scheduled administration of oral laxatives, and concludes with rectal administration of a bisacodyl suppository.223
In the usual regimen, 300 mL of magnesium citrate solution (17.45 g of magnesium citrate) is administered orally at 5:30 p.m. the day before the procedure, followed by 20 mg of bisacodyl orally at 7:30 p.m. the day before the procedure, and concludes with a 10-mg bisacodyl rectal suppository inserted at least 2 hours before the procedure.223
LoSo Prep Kit
Oral and Rectal
The regimen begins with liquid meals at prescribed times, followed by scheduled clear liquid intake at various times and scheduled administration of oral laxatives, and concludes with rectal administration of a bisacodyl suppository.232
In the usual regimen, 18 g of magnesium citrate (1 packet dissolved in 240 mL water) is administered orally at 5:30 p.m. the day before the procedure, followed by 20 mg of bisacodyl orally at 7:30 p.m. the day before the procedure, and concludes with a 10-mg bisacodyl rectal suppository inserted at least 2 hours before the procedure.232
OsmoPrep Sodium Phosphates Tablets
Oral
Evening before procedure: 1.592 g of dibasic sodium phosphate and 4.408 g of monobasic sodium phosphate (4 tablets) with 240 mL clear liquids; repeat every 15 minutes for 5 doses.213 Total dose 7.96 g of dibasic sodium phosphate and 22.04 g of monobasic sodium phosphate (20 tablets).213
Day of procedure: 1.592 g of dibasic sodium phosphate and 4.408 g of monobasic sodium phosphate (4 tablets) with 240 mL clear liquids every 15 minutes beginning 3–5 hours before the procedure.213 Repeat every 15 minutes for 3 doses.213 Total dose 4.776 g of dibasic sodium phosphate and 13.224 g of monobasic sodium phosphate (12 tablets).213
Total dosage is 12.736 g of dibasic sodium phosphate and 35.264 g of monobasic sodium phosphate with 1892 mL (2 quarts) of clear fluids.213 No additional enema or laxative is required.213
Tridrate Kit
Oral and Rectal
The regimen begins with a meal (i.e., clear liquids, chicken or turkey white meat sandwich without condiments, skim milk) at a prescribed time, followed by scheduled clear liquid intake at various times and scheduled administration of oral laxatives, and concludes with rectal administration of a bisacodyl suppository.222
In the usual regimen, 300 mL of magnesium citrate solution is administered orally at 8 p.m. the day before the procedure, followed by 15 mg of bisacodyl orally at 10 p.m. the day before the procedure, and concludes with a 10-mg bisacodyl rectal suppository at 7 a.m. the morning of the procedure.222
Tridrate Dry Kit
Oral and Rectal
The regimen begins with liquid meals at prescribed times, followed by scheduled clear liquid intake at various times and scheduled administration of oral laxatives, and concludes with rectal administration of a bisacodyl suppository.226
In the usual regimen, 19 g of magnesium citrate (1 packet dissolved in 240 mL water) is administered orally in 2 divided doses at 6 p.m. and 6:15 p.m. the day before the procedure, followed by 15 mg of bisacodyl orally at bedtime (between 9 p.m. and midnight) the day before the procedure, and concludes with a 10-mg bisacodyl rectal suppository at 7 a.m. the morning of (at least 2 hours before) the procedure.226
Visicol Sodium Phosphates Tablets
Oral
Evening before procedure: 1.194 g of dibasic sodium phosphate and 3.306 g of monobasic sodium phosphate (3 tablets) with 240 mL clear liquids; repeat every 15 minutes for 7 doses (last dose is 2 tablets).212 Total dose 7.96 g of dibasic sodium phosphate and 22.04 g of monobasic sodium phosphate (20 tablets).212
Day of procedure: 1.194 g of dibasic sodium phosphate and 3.306 g of monobasic sodium phosphate (3 tablets) with 240 mL clear liquids every 15 minutes beginning 3–5 hours before the procedure.212 Repeat every 15 minutes for 7 doses (last dose is 2 tablets).212 Total dose 7.96 g of dibasic sodium phosphate and 22.04 g of monobasic sodium phosphate (20 tablets).212
Total dosage is 15.92 g of dibasic sodium phosphate and 44.08 g of monobasic sodium phosphate (40 tablets) with 3405 mL (3.6 quarts) of clear fluids.212 No additional enema or laxative is required.212
Prescribing Limits
Pediatric Patients
Constipation
Laxatives should not be used for self-medication of constipation for ≥7 days without consulting clinician.214 215 216 217 218 219 220 221 223 225 231 232 b
Magnesium Citrate
Oral
Children 2–5 years of age: For self-medication, maximum 6.25 g (usually <90 mL [5.25 g] of a 291-mg/5-mL oral solution) daily.224 234
Children 6–11 years of age: For self-medication, maximum 12.5 g (usually <150 mL [8.75 g] of a 291-mg/5-mL oral solution) daily.224 234
Children ≥12 years of age: For self-medication, maximum 25 g (usually <300 mL [17.5 g] of a 291-mg/5-mL oral solution) daily.224 234
Magnesium Hydroxide
Oral
Children 2–5 years of age: For self-medication, maximum 1.2 g daily.217 233 234 235
Children 6–11 years of age: For self-medication, maximum 2.4 g daily.215 216 217 218 233 234 235
Children ≥12 years of age: For self-medication, maximum 4.8 g daily.215 216 217 218 233 234
Magnesium Sulfate
Oral
Children 2–5 years of age: For self-medication, maximum 5 g daily.234
Children 6–11 years of age: For self-medication, maximum 10 g daily.225 234
Children ≥12 years of age: For self-medication, maximum 30 g daily.225 234
Fixed Combination of Magnesium Hydroxide and Mineral Oil
Oral
Children 6–11 years of age: Maximum 1.8 g of magnesium hydroxide (30 mL of the fixed-combination suspension) daily.218
Children ≥12 years of age: Maximum 3.6 g of magnesium hydroxide (60 mL of the fixed-combination suspension) daily.218
Sodium Phosphates Enemas
Rectal
Children 2–4 years of age: For self-medication, maximum 1.75 g of dibasic sodium phosphate and 4.75 g of monobasic sodium phosphate (½ bottle [approximately 29 mL] of Fleet Pedia-Lax Enema) in 24 hours.227
Children 5–11 years of age: For self-medication, maximum 3.5 g of dibasic sodium phosphate and 9.5 g of monobasic sodium phosphate (1 bottle [approximately 59 mL] of Fleet Pedia-Lax Enema) in 24 hours.227
Children ≥12 years of age: For self-medication, maximum 7 g of dibasic sodium phosphate and 19 g of monobasic sodium phosphate (1 bottle of Fleet Enema [approximately 118 mL] or Fleet Enema Extra [approximately 197 mL]) in 24 hours.219 228
Bowel Cleansing
Sodium Phosphates Enemas
Rectal
Children 2–4 years of age: For self-medication, maximum 1.75 g of dibasic sodium phosphate and 4.75 g of monobasic sodium phosphate (½ bottle [approximately 29 mL] of Fleet Pedia-Lax Enema) in 24 hours.227
Children 5–11 years of age: For self-medication, maximum 3.5 g of dibasic sodium phosphate and 9.5 g of monobasic sodium phosphate (1 bottle [approximately 59 mL] of Fleet Pedia-Lax Enema) in 24 hours.227
Children ≥12 years of age: For self-medication, maximum 7 g of dibasic sodium phosphate and 19 g of monobasic sodium phosphate (1 bottle of Fleet Enema [approximately 118 mL] or Fleet Enema Extra [approximately 197 mL]) in 24 hours.228
Adults
Constipation
Laxatives should not be used for self-medication of constipation for ≥7 days without consulting clinician.214 215 216 217 218 219 220 221 223 225 231 232 b
Magnesium Citrate
Oral
For self-medication: Maximum 25 g (usually 300 mL [17.5 g] of a 291-mg/5-mL oral solution) daily.224 234
Magnesium Hydroxide
Oral
For self-medication: Maximum 4.8 g daily.215 216 217 218 233 234
Magnesium Sulfate
Oral
For self-medication: Maximum 30 g daily.225 234
Fixed Combination of Magnesium Hydroxide and Mineral Oil
Oral
For self-medication: Maximum 3.6 g of magnesium hydroxide (60 mL of the fixed-combination suspension) daily.218
Sodium Phosphates Enemas
Rectal
For self-medication: Maximum 7 g of dibasic sodium phosphate and 19 g of monobasic sodium phosphate (1 bottle of Fleet Enema [approximately 118 mL] or Fleet Enema Extra [approximately 197 mL]) in 24 hours.219 228
Bowel Cleansing
Sodium Phosphates Enemas
Rectal
For self-medication: Maximum 7 g of dibasic sodium phosphate and 19 g of monobasic sodium phosphate (1 bottle of Fleet Enema [approximately 118 mL] or Fleet Enema Extra [approximately 197 mL]) in 24 hours.219 228
OsmoPrep Sodium Phosphates Tablets
Oral
Do not repeat sodium phosphates tablet regimen for bowel cleansing within 7 days of previous administration.213
Visicol Sodium Phosphates Tablets
Oral
Do not repeat sodium phosphates tablet regimen for bowel cleansing within 7 days of previous administration.212
Special Populations
Hepatic Impairment
No specific dosage recommendations at this time.212 213
Renal Impairment
Magnesium laxatives not for self-medication in patients with renal disease.215 216 217 218 222 223 225 232 (See Contraindications under Cautions.)
Sodium phosphates not for use in patients with clinically important renal function impairment.219 220 (See Contraindications and also Renal Effects under Cautions.)
Geriatric Patients
Caution advised, but no specific dosage recommendations; consider possible age-related decrease in renal and/or cardiac function and concomitant disease and drug therapy.212 213 221 (See Geriatric Use under Cautions.)
Cautions for Saline Laxatives
Contraindications
Acute abdominal pain, nausea, vomiting, or other symptoms of appendicitis or undiagnosed abdominal pain.214 215 216 217 218 219 220 222 223 225 b
- Sodium Phosphates Preparations
Known hypersensitivity to sodium phosphate salts or any ingredient in the formulation.212 213 220
Biopsy-proven acute phosphate nephropathy212 or clinically important renal function impairment.219 220 221 227 228 229 230
CHF.219 220 221 227 228 229 230
Ascites.219 220 221 227 228
Known or suspected GI obstruction,219 220 221 227 228 congenital or acquired megacolon,219 220 221 227 228 perforation,220 221 ileus,220 221 or active inflammatory bowel disease.220 221
Oral solution for bowel cleansing: Pediatric patients <18 years of age.220 221 239
Rectal solutions: Pediatric patients <2 years of age.219
- Magnesium Preparations for Self-medication
Renal disease.215 216 217 218 223 224 225
Magnesium-restricted diet.215 216 217 218 224 225
Sudden change in bowel habits that lasts >14 days.215 216 217 218 224 225 b
Fixed combination of magnesium hydroxide and mineral oil: Pediatric patients <6 years of age, pregnancy, bedridden patients, or difficulty swallowing.218
Fixed combination of magnesium hydroxide and mineral oil: Concomitant use with stool softener laxatives.
No comments:
Post a Comment